Basic Information
ID: ALA5155123
Type: Functional
Description: Antiviral activity against SARS-CoV-2 infected in Vero E6 cells assessed as reduction in plaque formation incubated for 48 hrs by crystal violet staining based plaque reduction assay
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: Vero E6
Activity Charts
Bioactivity
Activity Types for Assay ALA5155123
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 507.54 | 0.54 | 0.54 |
| 634.73 | 2.86 | 2.86 |
| 687.72 | 4.18 | 4.18 |
| 570.69 | 2.88 | 2.88 |
| 509.99 | 2.12 | 2.12 |
| 591.67 | 2.54 | 2.54 |
| 673.69 | 3.79 | 3.79 |
| 664.72 | 4.35 | 4.35 |
| 591.67 | 2.54 | 2.54 |
| 633.75 | 3.47 | 3.47 |
| 726.67 | 5.19 | 5.19 |
| 659.57 | 4.46 | 4.46 |
| 591.67 | 2.54 | 2.54 |
| 590.68 | 3.15 | 3.15 |
| 581.67 | 2.38 | 2.38 |
| 622.72 | 2.50 | 2.50 |
| 486.57 | 1.28 | 1.28 |
| 624.66 | 3.42 | 3.42 |
| 614.70 | 1.99 | 1.99 |